Medplus Health Services Ltd's subsidiary Optival Health Solutions has received four suspension orders for drug licenses across various locations, resulting in potential revenue losses totaling approximately Rs 5.07 lakhs, with details available on their website. The suspension orders were issued on June 17, 2025, with varying durations from one to seven days.